The enhancement effect of pp38 gene product on the activity of its upstream bi-directional promoter in Marek's disease virus

Science in China, Series C: Life Sciences

Volumn 49, Issue 1, 2006, Pages 53-62

  Ding, Jiabo ^a   Cui, Zhizhong ^a   Jiang, Shijin ^a   Reddy, Sanjay ^b  

^a SHANDONG AGRICULTURAL UNIVERSITY   (China)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

1.8 kb mRNA transcript; Bi directional promoter; Marek's disease virus (MDV); pp38 gene; Trans acting factor

Indexed keywords

GALLID HERPESVIRUS 2; MARDIVIRUS;

EID: 33749848946     PISSN: 10069305     EISSN: 18622798     Source Type: Journal    
DOI: 10.1007/s11427-004-0119-y     Document Type: Article

References (32)

1. Bradley, G., Hayashi, M., Lancz, G. et al., Structure of the Marek's disease virus BamHI-H gene family: Genes of putative importance for tumor induction, J. Virol., 1989, 63: 2534-2542.
2. Bradley, G., Lancz, G., Tanaka, A. et al., Loss of Marek's disease virus tumorigenicity is associated with truncation of RNAs transcribed within BamHI-H, J. Virol., 1989b, 63: 4129-4135.
3. Cui, Z. Z., Lee, L. F., Liu, J. L. et al., Structural analysis and transcriptional mapping of the Marek's disease virus gene encoding pp38, an antigen associated with transformed cells, J. Virol., 1991, 65: 6509-6515.
4. Jones, D., Lee, L. F., Liu, J. L et al., Marek's disease virus encodes a basic-leucine zipper gene resembling the fos/jun oncogenes that is highly expressed in lymphoblastoid tumors, Proc. Natl. Acad. Sci. USA, 1992, 89: 4042-4046.
5. Xie, Q., Anderson, A. S., Morgan, R. W., Marek's disease virus (MDV) ICP4, pp38, and meq genes are involved in the maintenance of transformation of MDCC-MSB1 MDV-transformed lymphoblastoid cells, J. Virol., 1996, 70: 1125-1131.
6. Ikuta, K., Nakajima, K., Naito, M. et al., Identification of Marek's disease virus specific antigen in Marek's disease lymphoblastoid cell line using monoclonal antibody against virus-specific phosphorylated polypetides, Int. J. Cancer, 1985, 35: 257-264.
7. Nakajima, K., Ikuta, K., Naito, M. et al., Analysis of Marek's disease virus serotype 1-specific phosphorylated polypetides in virus-infected cells and Marek's disease lymphblastoid cells, J. Gen. Virol, 1987, 68: 1379-1389.
8. Endoh, D., Niikura, M., Hirai, K. et al., Expression and purification of recombinant Marek's disease virus serotype 1specific phosphated protein pp38 in E. coli., J. Vet. Med. Sci., 1994, 56: 823-826.
9. Pratt, W. D., Cantello, J., Morgan, R. W. et al., Enhanced expression of Marek's disease virus-specific phosphoproteins after stable transfection of MSB-1 cells with the Marek's disease virus homologue of ICP4, Virology, 1994, 201: 132-136.
10. Cui, Z. Z., Qin, A., Immunodepressive effects of the recombinant 38 kd phosphorylated protein of Marek's disease virus, in Current Research on Marek's Disease Virus(eds. Silva, R. F., Cheng, H. H., Coussens, P. M. et al.), Florida: Rose Printing Company, Inc., 1996, 278-283.
11. Baigent, S. J., Ross, L. J., Davison, T. F., Differential susceptibility to Marek's disease is associated with differences in number, but not phenotype or location, of pp38+ lymphocytes, J. Gen. Virol., 1998, 79: 2795-802.
12. Pratt, W. D, Morgan, R., Schat, K. A., Cell-mediated cytolysis of lymphoblastoid cells expressing Marek's disease virus-specific phosphorylated polypeptides, Vet. Microbiol., 1992, 33: 93-99.
13. Parcells, M. S., Dienglewicz, R. L., Anderson, A. S. et al., Recombinant Marek's disease virus (MDV)-derived lymphoblastoid cell lines: Regulation of a marker gene within the context of the MDV genome, J. Virol., 1999, 73: 1362-1373.
14. Reddy, S. M., Lupiani, B., Gimeno, I. M. et al., Rescue of a pathogenic Marek's disease virus with overlapping cosmid DNAs: Use of a pp38 mutant to validate the technology for the study of gene function, Proc. Natl. Acad. Sci. USA, 2002, 99: 7054-7059.
15. Maotani, K., Kanamori, A., Ikuta, K. et al., Amplification of a tandem direct repeat within inverted repeats of Marek's disease virus DNA during serial in vitro passage, J. Virol., 1986, 58: 657-659.
16. Peng, Q., Zeng, M., Bhuiyan, Z. A. et al., Isolation and characterization of Marek's disease virus (MDV) cDNA mapping to the BamH I-Q2 and BamH I-L fragments of the MDV genome from lymphoblastoid cells transformed and persistently infected with MDV, Virology, 1995, 213: 590-599.
17. Witter, R. L., Silva, R. F., Lee, L. F., New serotype 2 and attenuated serotype 1 Marek's disease vaccine viruses: Selected biological and molecular characteristics, Avian Dis., 1987, 31: 829-840.
18. Zhu, G. S., Ojima, T., Hironaka, T. et al., Differentiation of oncogenic and nononcogenic strains of Marek's disease virus type 1 by using polymerase chain reaction DNA amplification, Avian Dis., 1992, 36: 637-645.
19. Smith, G. D., Zelnik, V., Ross, L. J. N., Gene organization in herpesvirus of turkeys: Identification of a novel open reading frame in the long unique region and a truncated homologue od pp38 in the internal repeat, Virology, 1995, 207: 205-216.
20. Camp, H. S., Coussens, P. M., Silva, R. F., Cloning, sequencing, and functional analysis of a Marek's disease virus origin of DNA replication, J. Virol., 1991, 65: 6320-6324.
21. Katsumata, A., Iwata, A., Ueda, S., Cis-acting elements in the lytic origin of DNA replication of Marek's disease virus type 1, J. Gen. Virol., 1998, 79: 3015-3018.
22. Shigekane, H., Kawaguchi, Y., Shirakata, M. et al., The bi-directional transcriptional promoters for the latency-relating transcripts of the pp38/pp24 mRNAs and the 1.8 kb-mRNA in the long inverted repeats of Marek's disease virus serotype 1 DNA are regulatedby common promoter-specific enhancers, Arch Virol., 1999, 144: 1893-1907.
23. Eidson, C. S., Schmittle, S. C., Studies on acute Marek's disease. I. Characteristics of isolate GA in chickens, Avian Dis., 1968, 12: 467-476.
24. Ding, J. B., Cui, Z. Z., Sun, S. H. et al., A Bi-directional Promoter At the Upstream of pp38 Gene From Marek's Disease Virus. Acta Microbiol. Sin. (in Chinese), 2004, 44: 162-166.
25. Wu, T. F., Chen, H. H., Wu, H., Functional characterization of Marek's disease virus (MDV) origin-binding protein (OBP): Analysis of its origin-binding properties, Virus Genes, 2001, 23: 227-239.
26. Cui, Z. Z, Yan, Z. D., Lee, L. F., Marek's disease virus gene clons encoding virus-specific phosphorylatides polypetides and serological characterization of fusion protein, Virus Genes, 1990, 3: 309-322.
27. Cui, Z. Z., The affinity of 38kD phosphorylated protein gene product of Marek's disease virus, Chin. J. Virol., 2004, 20: 52-57.
28. Liu, J. L., Lin, S. F., Xia, L. et al., MEQ and V-IL8: Cellular genes in disguise? Acta virol., 1999, 43: 94-101.
29. Silva, R. F., Lee, L. F., Monoclonal antibody mediated immunoprecipitation of proteins from cells infected with Marek's disease virus or turkey herpes virus, Virology, 1984, 136: 307-320.
30. Zhu, G. S., Iwata, A., Gong, M. et al. Marek's disease virus type 1-specific phosphorylated protein pp38 and pp24 with common amino acid termini are ecoded from the opposite junction regions between the long unique and inverted repeat sequences of viral genome, Virology, 1994, 200: 816-820.
31. Cui, Z., Qin, A., Lee, L. F. et al., Construction and characterization of a H19 epitope point mutant of MDV CVI988/Rispens strain, Acta Virol., 1999, 43: 169-73.
32. Cui, Z. Z., Zhang, Z., Qin, A. J. et al., Analyzing the H19- and T65-epitopes in 38kd phosphorylated protein of Marek's disease - viruses and comparing chicken immunological reactions to viruses point-mutated in the epitopes, Science in China, Ser. C, 2004, 47: 82-91.